LA JOLLA PHARMACEUTICAL CO Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows, 13 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-05-26: Reporting owner SLOAN GAIL A; Form 4; Security Series C-2 Convertible Pfd Stock Warrants (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-05-26: Reporting owner SLOAN GAIL A; Form 4; Security Series D-1 Convertible Pfd Stock Warrants (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-05-26: Reporting owner Gillespie Deirdre; Form 4; Security Series C-2 Convertible Pfd Stock Warrants (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-05-26: Reporting owner Gillespie Deirdre; Form 4; Security Series D-1 Convertible Pfd Stock Warrants (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-05-26 | SLOAN GAIL A Officer (Chief Financial Officer) | 4 | Series C-2 Convertible Pfd Stock Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44 44 owned after | $1,000.00 exercise price | 2010-05-28 | |
| 2010-05-26 | SLOAN GAIL A Officer (Chief Financial Officer) | 4 | Series D-1 Convertible Pfd Stock Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22 22 owned after | $1,000.00 exercise price | 2010-05-28 | |
| 2010-05-26 | Gillespie Deirdre Director, Officer (President & CEO) | 4 | Series C-2 Convertible Pfd Stock Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +208 208 owned after | $1,000.00 exercise price | 2010-05-28 | |
| 2010-05-26 | Gillespie Deirdre Director, Officer (President & CEO) | 4 | Series D-1 Convertible Pfd Stock Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +104 104 owned after | $1,000.00 exercise price | 2010-05-28 | |
| 2008-05-12 | Frazier Healthcare V, LP 10% Owner | 4 | Warrants Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +259,844 259,844 owned after | $0.13 | 2009-02-12 | |
| 2008-05-12 | Gonzalez Alejandro 10% Owner | 4/A | Warrants Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +404,814 1,138,147 owned after | $2.15 | 2008-07-10 | |
| 2008-05-12 | Gonzalez Alejandro 10% Owner | 4 | Warrants Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +404,814 1,138,147 owned after | $0.13 | 2008-05-15 | |
| 2008-05-12 | SUTTER MARTIN P Director | 4 | Warrant Derivative · Indirect · By Essex Woodlands Health Ventures Fund VII, L.P. | P Open market or private purchase of non-derivative or derivative security | −1,951,854 1,951,854 owned after | $0.13 | 2008-05-14 | |
| 2008-05-12 | SUTTER MARTIN P Director | 4 | Warrant (right to buy) Derivative · Indirect · By Essex Woodlands Health Ventures Fund VI, L.P. | P Open market or private purchase of non-derivative or derivative security | −520,494 2,187,160 owned after | $0.13 | 2008-05-14 | |
| 2008-05-12 | ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner | 4 | Warrant Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +1,951,854 1,951,854 owned after | $0.13 | 2008-05-14 | |
| 2008-05-12 | ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 10% Owner | 4 | Warrant Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +520,494 2,187,160 owned after | $0.13 | 2008-05-14 | |
| 2006-02-14 holding as of filing | Topper James N Director | 5 | Warrants (right to buy) Derivative · Indirect · (m) | Holding | 1,000,000 owned after | no price filed | 2006-02-14 | |
| 2006-02-14 holding as of filing | Naini Nader J Director | 5 | Warrants (right to buy) Derivative · Indirect · (m) | Holding | 1,000,000 owned after | no price filed | 2006-02-14 |